This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Practice Fusion, a San Francisco-based EHR vendor with a controversy-rich history, has agreed to pay $145 million to settle allegations that it engaged in a kickback scheme designed to increase opioid prescriptions and issues with their meaningfuluse EHR certification. This had been […].
They discussed how AI can expedite the discovery of new drugs , along with why it helps to bring together the best AI professionals and experts from pharmaceutical companies. Read more… Exchanging, Managing, and Meaningfully Using Health Data in 2024. John Lynn connected with Mati Gill at AION Labs.
Our honeymoon commenced in April with what some pharmaceutical sponsors refer to as a “mandate” to show proof of a diversity, equity, and inclusion plan “as soon as practical” in the new drug application process, further solidified by the passage of the omnibus spending package at the end of 2022.
We had a small team that worked closely with pharmaceutical companies and generated revenue from these relationships. I wasn’t very involved with this team, but due to my ownership of many of the clinical decision support initiatives, I started getting invited to meetings we had with pharmaceutical companies.
In the context of US healthcare, many health record systems have focused on consistent representation for a key set of data elements defined by the MeaningfulUse Common Clinical Data Set. Open standards, open specifications, and open source tools are essential to facilitate frictionless data exchange.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content